Arndt Asperger, Ph.D., Senior Applications Scientist Bruker Life Sciences Mass Spectrometry, GmbH & Co. KG, Bremen, Germany.
This webinar will demonstrate the unique capabilities of next-gen MALDI-TDS for in-depth analysis of various pharmaceutical proteins, e.g monoclonal antibodies and viral protein receptor binding domains, and will discuss how the method further expands the biologics toolkit featured by Bruker´s timsTOF fleX ESI/MALDI instrument.
Attend this webinar to learn more about:
- The benefits of next-gen MALDI-TDS for the characterization of modern biotherapeutics
- The unique contributions of trapped ion mobility to N- and C-terminal sequencing
- The timsTOF fleX biologics toolkit integrating ESI and MALDI workflows.
Run time: 47:21 mins
Expanding the Biologics Toolkit With Next-Generation MALDI Top-Down Sequencing
Video Credit: Bruker Life Sciences Mass Spectrometry